After the healthcare and consumer goods company posted first quarter adjusted earnings per share (EPS) of $2.68, 18 cents over Wall Street analysts’ projections, Johnson & Johnson (JNJ) stock increased
Read More
JOHNSON & JOHNSON is trading up 1.97% at 170.02 Johnson & Johnson on Tuesday beat Wall Street estimates for quarterly revenue and profit on strong demand for its cancer drug